Menu Philippe 4

What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 5,000 shares on 2026-07-13 in an open-market/private sale. The reported weighted-average price was $5.70 per share, for total proceeds of $28,505. This was a sale (commonly routine) and was executed pursuant to a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-07-13; filing dated 2026-07-14 (timely).
• Price: weighted average $5.70; transaction prices ranged from $5.55 to $5.79 (footnote).
• Shares sold: 5,000; proceeds: $28,505.
• Shares owned after the transaction: not disclosed in this Form 4.
• Notable footnotes: sale made under a duly adopted 10b5-1(c) plan; weighted-average price reported with offer to provide a per-price breakdown on request.
• Filing timeliness: appears timely (no late-filing indication).

Context: Sales made under 10b5-1 plans are pre-scheduled and are often routine disposition transactions; this filing is factual and does not by itself indicate a change in insider sentiment.